News | September 13, 2007

Breast Cancer Charity Announces New Strategy to Improve Prevention, Early Diagnosis

September 14, 2007 - With breast cancer affecting over 44,000 women and 300 men each year in the UK, the breast cancer charity, Breakthrough Breast Cancer revealed plans to open three new dedicated research units, which will investigate ways to prevent breast cancer and improve diagnosis and treatments for the disease.

Breakthrough Breast Cancer needs to raise at least 25 million euro each year for the next three years to support its vital research, campaigning and education work. Breast cancer is reportedly now the most commonly diagnosed cancer in the UK yet a recent study found survival rates in the UK to be among the worst in Europe.

The Breakthrough Breast Cancer Research Units will be based in Edinburgh, Manchester and London and will each focus on a specific area of breast cancer research. In Scotland, the new unit will aim to improve and develop treatments for breast cancer. In Manchester, the team will focus on developing new ways to detect and prevent early breast cancer and the new London unit will investigate a poorly understood type of breast cancer called basal-like breast cancer, which is more common amongst young women and those of African origin.

Each unit will have strong links with a major cancer hospital or breast unit and research institute or university. The units will complement work already taking place at the internationally renowned Breakthrough Toby Robins Breast Cancer Research Centre based in the Mary-Jean Mitchell Green Building at The Institute of Cancer Research in London, which was the UK's first dedicated breast cancer research facility.

For more information: www.breakthrough.org.uk

Related Content

breast screening
News | Clinical Trials | September 13, 2018
Fewer and fewer women die from breast cancer in recent years but, surprisingly, the decline is just as large in the a
Lightvision near-infrared fluorescence imaging system
News | Women's Health | September 11, 2018
Shimadzu Corp.
Feature | Breast Imaging | September 07, 2018 | By JoAnn Pushkin
If you are confused about the conflicting advice surrounding mammography screening guidelines, welcome to the club.
Illinois Governor Approves State Breast Density Reporting Bill Into Law
News | Breast Density | August 13, 2018
Illinois Gov. Bruce Rauner approved the Illinois Breast Density Reporting Law (Public Act 100-0749) on Aug. 10, 2018...
PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis
Technology | Breast Density | August 08, 2018
iCAD announced U.S. Food and Drug Administration (FDA) clearance of its latest artificial intelligence (AI) software...
Cardiac Imaging Reveals Roots of Preeclampsia Damage in Pregnant Women
News | Women's Health | August 07, 2018
Johns Hopkins researchers say a heart imaging study of scores of pregnant women with the most severe and dangerous form...
Cardiac Monitoring a Higher Priority for High-Risk Breast Cancer Patients
News | Cardio-oncology | August 07, 2018
August 7, 2018 — While heart failure is an uncommon complication of...
Hologic Acquires Digital Specimen Radiography Company Faxitron Bioptics

VisionCT 3-D breast specimen-designated computed tomography (CT) system. Image courtesy of Faxitron Bioptics.

News | Breast Imaging | July 31, 2018
Hologic Inc. announced it has completed the acquisition of Faxitron Bioptics, a privately-held leader in digital...